These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38816586)

  • 21. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin and neuroplasticity - Links between molecular, functional and structural pathophysiology in depression.
    Kraus C; Castrén E; Kasper S; Lanzenberger R
    Neurosci Biobehav Rev; 2017 Jun; 77():317-326. PubMed ID: 28342763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.
    Kozlowska U; Nichols C; Wiatr K; Figiel M
    J Neurochem; 2022 Jul; 162(1):89-108. PubMed ID: 34519052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are Noradrenergic Transmission Reducing Drugs Antidepressants?
    Fitzgerald PJ
    Front Behav Neurosci; 2021; 15():673634. PubMed ID: 34658805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions.
    Fogaça MV; Duman RS
    Front Cell Neurosci; 2019; 13():87. PubMed ID: 30914923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis.
    Pastis I; Santos MG; Paruchuri A
    Front Behav Neurosci; 2023; 17():1282242. PubMed ID: 38299049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
    Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
    CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synaptic plasticity model of therapeutic sleep deprivation in major depression.
    Wolf E; Kuhn M; Normann C; Mainberger F; Maier JG; Maywald S; Bredl A; Klöppel S; Biber K; van Calker D; Riemann D; Sterr A; Nissen C
    Sleep Med Rev; 2016 Dec; 30():53-62. PubMed ID: 26803484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder.
    McIntyre RS; Suppes T; Tandon R; Ostacher M
    J Clin Psychiatry; 2017 Jun; 78(6):703-713. PubMed ID: 28682531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder.
    Zuckerman H; Pan Z; Park C; Brietzke E; Musial N; Shariq AS; Iacobucci M; Yim SJ; Lui LMW; Rong C; McIntyre RS
    Front Psychiatry; 2018; 9():655. PubMed ID: 30564155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroplasticity and memory formation in major depressive disorder: an imaging genetics perspective on serotonin and BDNF.
    Kuhn M; Popovic A; Pezawas L
    Restor Neurol Neurosci; 2014; 32(1):25-49. PubMed ID: 23603442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research.
    Amidfar M; Woelfer M; Réus GZ; Quevedo J; Walter M; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109668. PubMed ID: 31207274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5-HT
    Tiger M; Varnäs K; Okubo Y; Lundberg J
    Psychopharmacology (Berl); 2018 May; 235(5):1317-1334. PubMed ID: 29546551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major depressive disorder: hypothesis, mechanism, prevention and treatment.
    Cui L; Li S; Wang S; Wu X; Liu Y; Yu W; Wang Y; Tang Y; Xia M; Li B
    Signal Transduct Target Ther; 2024 Feb; 9(1):30. PubMed ID: 38331979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives.
    Shin C; Kim YK
    Psychiatry Investig; 2020 Mar; 17(3):181-192. PubMed ID: 32209965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data?
    Puryear CB; Brooks J; Tan L; Smith K; Li Y; Cunningham J; Todtenkopf MS; Dean RL; Sanchez C
    Neurosci Biobehav Rev; 2020 Jan; 108():658-678. PubMed ID: 31821832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manipulating facial musculature with functional electrical stimulation as an intervention for major depressive disorder: a focused search of literature for a proposal.
    Demchenko I; Desai N; Iwasa SN; Gholamali Nezhad F; Zariffa J; Kennedy SH; Rule NO; Cohn JF; Popovic MR; Mulsant BH; Bhat V
    J Neuroeng Rehabil; 2023 May; 20(1):64. PubMed ID: 37193985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI).
    McIntyre RS; Lee Y
    Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.